Clinical Trials on High Risk Solid Tumors in Switzerland
Total 128 results
-
PfizerCompletedSolid TumorsUnited States, Australia, Italy, Greece, Sweden, Switzerland, United Kingdom, Canada, Singapore, France, Netherlands
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
Novartis PharmaceuticalsRecruitingAdvanced Solid TumorsSwitzerland, Belgium, Italy, Spain, Germany, Hong Kong, Hungary, Korea, Republic of, China, Czechia, Canada, United States, France, Poland, Thailand, Netherlands, Taiwan
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersSpain, Switzerland, United Kingdom, United States
-
Hoffmann-La RocheCompletedSolid TumorsUnited States, Denmark, Spain, Switzerland, Netherlands, Canada
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors, Excluding Breast CancerNetherlands, Switzerland, Denmark, United States
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorsSpain, Japan, Taiwan, Italy, Switzerland, Israel, United States, Singapore
-
Merck Sharp & Dohme LLCRecruitingAdvanced or Metastatic Solid TumorsCanada, Switzerland, United States
-
Novartis PharmaceuticalsCompletedMetastatic or Locally Advanced Solid TumorsNetherlands, Spain, Germany, Switzerland, Belgium
-
Array Biopharma, now a wholly owned subsidiary...CompletedAdvanced Solid Tumors | Selected Solid TumorsUnited States, Germany, Canada, Spain, Netherlands, Singapore, Switzerland
-
Hoffmann-La RocheRecruitingSolid TumorsBelgium, United States, Australia, Canada, Japan, Korea, Republic of, United Kingdom, Germany, Taiwan, China, Puerto Rico, Israel, Singapore, Spain, Brazil, Portugal, South Africa, Denmark, France, Italy, Poland, Hong Kong, New Zealand and more
-
Oncology Institute of Southern SwitzerlandEnte Ospedaliero Cantonale, Bellinzona; Istituto Cantonale di PatologiaRecruitingLymphoma | Advanced Solid TumorSwitzerland
-
University Hospital, Basel, SwitzerlandNot yet recruiting
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid TumorsChina, United States, Australia, Canada, Chile, Israel, Japan, Korea, Republic of, Panama, Poland, Spain, Switzerland, Turkey, New Zealand, Taiwan, Denmark
-
PfizerCompletedSolid Tumors Harboring a BRAF V600 MutationUnited States, France, Italy, Singapore, Australia, Spain, Switzerland, Canada, Belgium
-
Brigham and Women's HospitalNational Institute of Mental Health (NIMH); Yale University; OrygenRecruitingPsychosis | Remission | Conversion | Clinical High RiskUnited States, United Kingdom, Canada, Italy, Australia, Chile, China, Denmark, Germany, Hong Kong, Korea, Republic of, Singapore, Spain, Switzerland
-
Ethical Oncology ScienceCompletedLymphoma, Non-Hodgkin | Solid TumorsSwitzerland, Italy
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingAdvanced or Metastatic Solid TumorsUnited States, China, Croatia, Japan, Latvia, Poland, Brazil, Lithuania, Switzerland
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Norway, United Kingdom, Switzerland, Netherlands, Belgium, Austria, Denmark, Germany
-
European Organisation for Research and Treatment...SuspendedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
European Organisation for Research and Treatment...WithdrawnUnspecified Adult Solid Tumor, Protocol SpecificFrance, Norway, Switzerland, Netherlands, Belgium, Austria, United Kingdom, Denmark, Germany
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
Swiss Group for Clinical Cancer ResearchCompletedUnspecified Adult Solid Tumor, Protocol Specific | Nausea and VomitingSwitzerland, Italy
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Novartis PharmaceuticalsCompletedAdvanced and Selected Solid TumorsBelgium, Spain, Canada, Switzerland, United States
-
Incyte CorporationTerminatedSolid Tumor MalignancyUnited States, France, United Kingdom, Italy, Korea, Republic of, Japan, Spain, Israel, Denmark, Germany, Switzerland
-
AmgenActive, not recruitingKRAS p.G12C Mutant Advanced Solid TumorsUnited States, France, Canada, Spain, Belgium, Korea, Republic of, Austria, Australia, Hungary, Greece, Germany, Japan, Romania, Switzerland, Brazil, Portugal
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Spain, Denmark, Netherlands, Norway, Belgium, United Kingdom, Israel, Italy, Switzerland, Germany, Austria, Greece, Portugal
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Childhood Solid Tumor, Protocol SpecificUnited States, Australia, Canada, Switzerland
-
Hoffmann-La RocheTerminatedSolid TumorUnited States, Spain, Canada, United Kingdom, Denmark, France, Germany, Israel, Italy, Netherlands, Switzerland
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Recurrent or Refractory Medulloblastoma | Locally Advanced or Metastatic Basal Cell CarcinomaUnited States, United Kingdom, Switzerland, Netherlands
-
BayerActive, not recruitingSolid Tumors Harboring NTRK FusionUnited States, China, Poland, Australia, Germany, Japan, Canada, Italy, Czechia, Spain, Turkey, United Kingdom, Sweden, Netherlands, France, Switzerland, Korea, Republic of, Denmark, Ireland, Israel, Ukraine
-
Day One Biopharmaceuticals, Inc.Pacific Pediatric Neuro-Oncology ConsortiumRecruitingAdvanced Solid Tumor | Low-grade GliomaUnited States, Israel, Korea, Republic of, Denmark, Singapore, Netherlands, Canada, Australia, Germany, Switzerland, United Kingdom
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Ovarian Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Liver Cancer | Psychosocial Effects of Cancer and Its Treatment | Extragonadal Germ Cell Tumor | Childhood Germ Cell TumorUnited States, Puerto Rico, Canada, Switzerland
-
Swiss Group for Clinical Cancer ResearchCompleted
-
European Organisation for Research and Treatment...CompletedTesticular Germ Cell Tumor | Unspecified Adult Solid Tumor, Protocol SpecificFrance, Netherlands, Norway, Belgium, Switzerland, Austria, United Kingdom, Germany, Denmark
-
Amsterdam UMCRecruitingBarrett Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaNetherlands, Belgium, Australia, United Kingdom, Germany, Switzerland
-
AmgenRecruitingAdvanced MTAP-null Solid TumorsUnited States, Canada, Taiwan, Switzerland, United Kingdom, Korea, Republic of, Germany, Austria, France, Belgium, Australia, Hong Kong, Japan
-
European Organisation for Research and Treatment...CompletedUnspecified Adult Solid Tumor, Protocol SpecificFrance, Spain, Denmark, Netherlands, Norway, Belgium, United Kingdom, Israel, Italy, Switzerland, Germany, Portugal, Greece, Austria
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownBarrett Esophagus | Adenocarcinoma Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal AdenocarcinomaFrance, United Kingdom, Belgium, Germany, Switzerland, Australia, Netherlands
-
BayerRecruitingLocally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene FusionUnited States, Austria, Denmark, Germany, Italy, Norway, Spain, United Kingdom, Brazil, Russian Federation, Switzerland, Taiwan, Canada, China, Australia, Greece, Belgium, Sweden, Korea, Republic of, France, Argentina, Finland, Ireland and more
-
ECRI bvUniversity of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaboratorsCompletedCoronary Artery Disease | PCI | High Bleeding RiskNetherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
-
Novartis PharmaceuticalsTerminatedMelanoma | Ovarian Cancer | NSCLC | Other Solid TumorsItaly, Spain, Netherlands, France, Korea, Republic of, Switzerland, Germany, Japan, United States, Canada
-
AstraZenecaParexel; Iqvia Pty Ltd; Medidata Solutions; CISCRPActive, not recruitingSolid TumorSpain, United Kingdom, United States, Canada, Czechia, Poland, Romania, Thailand, Vietnam, Belgium, France, Korea, Republic of, Brazil, Hungary, Japan, Russian Federation, Malaysia, Taiwan, Australia, Germany, Turkey, Ukraine, Nethe... and more
-
Anaveon AGRecruitingLung Cancer | Advanced Solid Tumor | Adult DiseaseUnited Kingdom, Switzerland, Spain
-
National Cancer Institute (NCI)Children's Oncology GroupCompletedUnspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | NeurotoxicityUnited States, Canada, Australia, Switzerland
-
Incyte CorporationRecruitingSolid TumorsUnited States, Japan, France, Italy, United Kingdom, Netherlands, Switzerland
-
Novartis PharmaceuticalsTerminatedSolid Tumors and LymphomasUnited States, Australia, Netherlands, Canada, Germany, Switzerland, Japan, Spain
-
Merck Sharp & Dohme LLCRecruitingSolid Tumors | Hematologic MalignanciesUnited States, Poland, Brazil, Ukraine, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic... and more
-
Ablynx, a Sanofi companyCompletedUnstable Angina | Non ST Segment Elevation Myocardial Infarction (NSTEMI) | Stable Angina (Associated With High Risk PCI)Poland, Belgium, Germany, Israel, Austria, Switzerland, Czechia